BarbriSFCourseDetails
  • videocam On-Demand
  • signal_cellular_alt Intermediate
  • card_travel Health
  • schedule 90 minutes

Private Equity Transactions in Healthcare: Stark, AKS, and Other Compliance Challenges

Structuring Purchase Price, Restrictive Covenants, Indemnities, Equity Rollovers, and More

$297.00

This course is $0 with these passes:

BarbriPdBannerMessage

Description

Private equity firms play an active role in healthcare deals. The healthcare sector is seeking and drawing private equity firms' attention for investment in long-term care, urgent care, surgery centers, health IT companies, behavioral health, and dental practices. Many shifted their attention to telehealth when the COVID-19 pandemic hit.

Counsel must consider several factors when structuring private equity transactions, including purchase price issues, deal structure, and tax implications, as well as Stark, Anti-Kickback Statute, and other regulatory matters.

Listen as our authoritative panel examines the nuts and bolts of healthcare private equity transactions. The panel will discuss purchase price considerations, tax structures, deal terms, and indemnities. The panel will also guide in addressing regulatory issues in healthcare private equity transactions.

Presented By

Scott Paterson
Withum
Glenn P. Prives
Shareholder
Baker, Donelson, Bearman, Caldwell & Berkowitz PC

Mr. Prives helps clients navigate the strict regulatory structure of the healthcare industry. Clients appreciate that he is a practical healthcare and corporate law attorney who negotiates hard to get their deals done. His experience on behalf of healthcare clients encompasses hospital-physician alignment, private equity transactions, mergers and acquisitions, affiliations, alliances, strategic transactions, joint ventures, recruitment matters, the drafting and negotiation of contractual agreements, healthcare information technology issues, integrated delivery systems (population health), and clinical integration matters. Clients also seek out his advice on a variety of healthcare regulatory matters, including the Stark Law, the Anti-Kickback Statute, state self-referral laws, fraud and abuse, HIPAA, health care reform, Medicare and Medicaid issues, coverage and overpayment issues, compliance, regulatory and due diligence reviews, licensure and certification issues, the corporate practice of medicine, and fee-splitting laws.

Patrick D. Souter
Of Counsel
Gray Reed & Mcgraw LLP

Mr. Souter is known for his legal and educational experience in the healthcare industry, making him a sought-after resource for clients and students alike. His primary areas of practice are related to transactional and administrative healthcare, corporate, securities and antitrust matters. Mr. Souter is also a Professor of Healthcare Studies at Baylor University School of Law where he oversees the healthcare law program and teaches Healthcare Law, Healthcare Fraud and Abuse and Regulation of Healthcare Professionals. He is also involved with the Robbins Institute for Health Policy and Leadership at the Baylor University Hankamer School of Business where he teaches Healthcare Law and Ethics in its M.B.A. in Healthcare Administration Program and Executive M.B.A. Program.

Credit Information
  • This 90-minute webinar is eligible in most states for 1.5 CLE credits.


  • Live Online


    On Demand

Date + Time

  • event

    Tuesday, September 12, 2023

  • schedule

    1:00 p.m. ET./10:00 a.m. PT

  1. Purchase price considerations
  2. Deal and tax structuring and the impact of legacy tax structures and the corporate practice of medicine
  3. Common deal terms and indemnities
  4. Regulatory issues
  5. Restrictive covenants
  6. Equity rollover considerations and structuring of governance, puts/calls, and tag-along/drag-along considerations

The panel will review these and other noteworthy issues:

  • What hurdles do counsel encounter when involving private equity firms in healthcare transactions?
  • What factors should counsel keep in mind when determining price and deal structure?
  • What best practices should counsel employ to ensure regulatory compliance in a healthcare private equity transaction?